CS logo
small CS logo
Albany House Medical Centre

Wellingborough, United Kingdom
Medical center in Wellingborough, England
3 Queen St, Wellingborough NN8 4RW

About Albany House Medical Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Albany House Medical Centre


During the past decade, Albany House Medical Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Albany House Medical Centre" #1 sponsor was "Pfizer" with 2 trials, followed by "Galderma R&D" with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "LEO Pharma" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

Clinical Trials Conditions at Albany House Medical Centre


According to Clinical.Site data, the most researched conditions in "Albany House Medical Centre" are "Cardiovascular Disease" (2 trials), "Acne" (1 trials), "Depression" (1 trials), "Obesity" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Albany House Medical Centre" in a lesser frequency.

Clinical Trials Intervention Types at Albany House Medical Centre


Most popular intervention types in "Albany House Medical Centre" are "Drug" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg" (1 trials), "Decapeptyl® SR 22.5mg" (1 trials) and "JNJ-64565111 Dose Level 1" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Albany House Medical Centre


The vast majority of trials in "Albany House Medical Centre" are 6 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Albany House Medical Centre


Currently, there are NaN active trials in "Albany House Medical Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Albany House Medical Centre, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Albany House Medical Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".